Back

Full combination of guideline-recommended medical therapy is associated with better long-term mortality in acute heart failure patients with low blood pressure and renal dysfunction

25 August 2018 (12:35 - 13:25)
Organised by:
Congress Presentation Part of: New aspects of heart failure treatment Pharmacotherapy ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Motoko Kametani

Tokyo Women's Medical University, Tokyo (Japan)

6 More presentations in this session

Presentation thumbnail
Additional use of SGLT2 inhibitors in the treatment of acute decompensated heart failure may prevent acute kidney injury
Doctor T. Kambara (Seto, JP)
Abstract Slides
Presentation thumbnail
Impact of catheter ablation for atrial fibrillation on clinical outcome in elderly patients hospitalized for acute heart failure
Doctor M. Manita (Naha, JP)
Abstract Slides
Presentation thumbnail
Cystatin C-based estimated glomerular filtration rate to predict diuretic response to tolvaptan in acute decompensated heart failure
Doctor K. Tsuchida (Niigata, JP)
Abstract Slides
Presentation thumbnail
Heart failure specialist nurse-led day case ambulatory management with intravenous diuretics reduces hospitalisations for acute decompensated heart failure irrespective of ejection fraction
Mrs S. Hassan (Liverpool, GB)
Abstract Slides
Presentation thumbnail
Comparison of changes in the plasma volume and renal function between acetazolamide vs. conventional diuretics: understanding their mechanical differences according to the chloride theory
Doctor H. Kataoka (Saiki, JP)
Abstract Slides

Access the full session

Session thumbnail
New aspects of heart failure treatment

The Event

Event poster

ESC Congress 2018

25 August 2018 12:35 CET
You may be interested in
thumbnail
Congress Session
Acute heart failure therapies: from clinical trials to clinical practice
thumbnail
Congress Session
Devices in acute heart failure
thumbnail
Congress Session
Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources